tiprankstipranks
Trending News
More News >
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
India Market

Suven Pharmaceuticals Ltd. (SUVENPHAR) Income Statement

Compare
2 Followers

Suven Pharmaceuticals Ltd. Income Statement

Last quarter (Q3 2025), Suven Pharmaceuticals Ltd.'s total revenue was ₹3.07B, an increase of 39.73% from the same quarter last year. In Q3, Suven Pharmaceuticals Ltd.'s net income was ₹828.80M. See Suven Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 11.98B₹ 10.51B₹ 13.40B₹ 12.90B₹ 9.80B
Gross Profit
₹ 8.92B₹ 6.03B₹ 7.55B₹ 7.35B₹ 5.60B
Operating Expenses
₹ 5.95B₹ 1.40B₹ 2.36B₹ 1.92B₹ 1.48B
Depreciation and Amortization
₹ 774.90M₹ 545.96M₹ 477.32M₹ 390.97M₹ 316.36M
EBITDA
₹ 4.34B₹ 4.68B₹ 6.20B₹ 6.74B₹ 4.57B
Operating Income
₹ 2.98B₹ 4.61B₹ 5.19B₹ 5.42B₹ 4.10B
Other Income/Expenses
₹ 462.10M₹ -550.93M₹ -706.22M₹ 342.03M₹ -153.90M
Pretax Income
₹ 3.44B₹ 4.06B₹ 5.60B₹ 6.68B₹ 4.68B
Net Income
₹ 2.65B₹ 3.00B₹ 4.11B₹ 4.54B₹ 3.62B
Per Share Metrics
Basic EPS
₹ 10.52₹ 11.80₹ 16.16₹ 17.83₹ 14.23
Diluted EPS
₹ 10.45₹ 11.80₹ 16.16₹ 17.83₹ 14.23
Weighted Average Shares Outstanding
251.68M 254.48M 254.56M 254.56M 254.56M
Weighted Average Shares Outstanding (Diluted)
253.37M 254.56M 254.56M 254.56M 254.56M
Currency in INR

Suven Pharmaceuticals Ltd. Earnings and Revenue History